218 related articles for article (PubMed ID: 27890007)
1. A Current Perspective on the Inhibition of Cholinesterase by Natural and Synthetic Inhibitors.
Shah AA; Dar TA; Dar PA; Ganie SA; Kamal MA
Curr Drug Metab; 2017; 18(2):96-111. PubMed ID: 27890007
[TBL] [Abstract][Full Text] [Related]
2. Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.
Martinez A; Castro A
Expert Opin Investig Drugs; 2006 Jan; 15(1):1-12. PubMed ID: 16370929
[TBL] [Abstract][Full Text] [Related]
3. BChE inhibitors from marine organisms - A review.
Lins Alves LK; Cechinel Filho V; de Souza RLR; Furtado-Alle L
Chem Biol Interact; 2022 Nov; 367():110136. PubMed ID: 36096160
[TBL] [Abstract][Full Text] [Related]
4. Determination of Anti-Alzheimer's Disease Activity of Selected Plant Ingredients.
Tuzimski T; Petruczynik A
Molecules; 2022 May; 27(10):. PubMed ID: 35630702
[TBL] [Abstract][Full Text] [Related]
5. Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease.
Konrath EL; Passos Cdos S; Klein LC; Henriques AT
J Pharm Pharmacol; 2013 Dec; 65(12):1701-25. PubMed ID: 24236981
[TBL] [Abstract][Full Text] [Related]
6. Cholinesterase inhibition in Alzheimer's disease: is specificity the answer?
Macdonald IR; Rockwood K; Martin E; Darvesh S
J Alzheimers Dis; 2014; 42(2):379-84. PubMed ID: 24898642
[TBL] [Abstract][Full Text] [Related]
7. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
[TBL] [Abstract][Full Text] [Related]
8. Cholinesterases, a target of pharmacology and toxicology.
Pohanka M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):219-29. PubMed ID: 22286807
[TBL] [Abstract][Full Text] [Related]
9. Coumarins as cholinesterase inhibitors: A review.
de Souza LG; Rennã MN; Figueroa-Villar JD
Chem Biol Interact; 2016 Jul; 254():11-23. PubMed ID: 27174134
[TBL] [Abstract][Full Text] [Related]
10. Nature as a source of metabolites with cholinesterase-inhibitory activity: an approach to Alzheimer's disease treatment.
Pinho BR; Ferreres F; Valentão P; Andrade PB
J Pharm Pharmacol; 2013 Dec; 65(12):1681-700. PubMed ID: 24236980
[TBL] [Abstract][Full Text] [Related]
11. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
12. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C
Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945
[TBL] [Abstract][Full Text] [Related]
13. [Acetylcholinesterase inhibitors in Alzheimer's disease: further comments on their mechanisms of action and therapeutic consequences].
Nieoullon A
Psychol Neuropsychiatr Vieil; 2010 Jun; 8(2):123-31. PubMed ID: 20525543
[TBL] [Abstract][Full Text] [Related]
14.
Mahomoodally F; Abdallah HH; Suroowan S; Jugreet S; Zhang Y; Hu X
Curr Pharm Des; 2020; 26(33):4151-4162. PubMed ID: 32178608
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation and docking studies of 2,3-dihydroquinazolin-4(1H)-one derivatives as inhibitors of cholinesterases.
Sarfraz M; Sultana N; Rashid U; Akram MS; Sadiq A; Tariq MI
Bioorg Chem; 2017 Feb; 70():237-244. PubMed ID: 28126287
[TBL] [Abstract][Full Text] [Related]
16. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
[TBL] [Abstract][Full Text] [Related]
17. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
[TBL] [Abstract][Full Text] [Related]
19. Anti-ovarian cancer potential, in silico studies, and anti-Alzheimer's disease effects of some natural compounds as cholinesterase inhibitors.
Fu M; Ji C; Yang T; Mao F; Shati AA; El-Kott AF; El-Maksoud MMA; Negm S; Ji Y
Biotechnol Appl Biochem; 2023 Jun; 70(3):1085-1099. PubMed ID: 36515452
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholinesterase inhibitors from plants.
Mukherjee PK; Kumar V; Mal M; Houghton PJ
Phytomedicine; 2007 Apr; 14(4):289-300. PubMed ID: 17346955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
